STAGE III NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE III NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE III NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE III NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung cancer radiation study pulled before it even started
Symptom relief TerminatedThis study aimed to see if a newer, daily-adaptive radiation technique could reduce coughing, breathing trouble, and swallowing pain in people with stage III non-small cell lung cancer getting chemo and radiation. It planned to compare the adaptive method to standard radiation. H…
Matched conditions: STAGE III NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Thymus gland may hold key to preventing immune cell loss during lung cancer treatment
Knowledge-focused OngoingThis study looks at whether the size and shape of the thymus gland, along with the radiation dose it receives, can predict a drop in immune cells (lymphocytes) during chest radiation for stage III lung cancer. Researchers will collect data from standard scans and blood tests of 4…
Matched conditions: STAGE III NON-SMALL CELL LUNG CANCER
Sponsor: You Peimeng • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC